Athenahealth May Drop to $110 Without Elliott Bid Says RBC
Athenahealth may suffer now that Elliott is reportedly backing off from its bid.

Ruh-roh.

On Monday, Sept. 18, The New York Post reported that Elliott Management, Paul Singer's hedge fund, is backing away from its $160-per-share bid for Athenahealth (ATHN) .

RBC analyst George Hill wrote, "absent the bid, we suspect Athenahealth shares could fall back to the $110-$120 range where they traded prior to the activist bid."

On Tuesday, Athenahealth was down 5% to around $135 a share in morning trading.

The bid for a total sum of $6.9 billion was first made in May. The Post reported that Elliott while backing away from the initial bid, may be interested in lowering the price. 

Athena's deadline for bidding is now Sept. 27, which is 10 days longer than the company originally offered. 

Elliott has taken an activist role in Athenahealth, forcing CEO Jonathan Bush out in June. 

In the past three months, shares of Athenahealth have dropped around 10%.

More from Markets

Data Regulation on FAANG's Could Just Be Underway: Cramer's Investing Teach-in

Data Regulation on FAANG's Could Just Be Underway: Cramer's Investing Teach-in

Your Need to Know - Forward Look

Your Need to Know - Forward Look

3 Things Investors Can Do to Stay Strategic When the Market's Volatile

3 Things Investors Can Do to Stay Strategic When the Market's Volatile

How to Be a Tactical Investor in the Current Market

How to Be a Tactical Investor in the Current Market

How E-Mini S&P 500 Revolutionized Equity, Electronic Trading

How E-Mini S&P 500 Revolutionized Equity, Electronic Trading